国药股份前三季度净利14.92亿元，同比增长0.74%

Core Insights - China National Pharmaceutical Group Corporation (国药股份) reported its Q3 2025 results, showing a revenue of 39.381 billion yuan, representing a year-on-year growth of 3.56% [1] - The net profit attributable to shareholders reached 1.492 billion yuan, reflecting a year-on-year increase of 0.74% [1] Financial Performance - The company achieved a total operating income of 39.381 billion yuan in the first three quarters of 2025 [1] - The year-on-year growth in revenue was 3.56%, indicating a steady performance in the market [1] - The net profit attributable to the company was 1.492 billion yuan, with a slight increase of 0.74% compared to the previous year [1]